TY - JOUR
T1 - Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension
AU - Freed, Benjamin H.
AU - Patel, Amit R.
AU - Lang, Roberto M.
N1 - Funding Information:
Disclosure Conflicts of interest: B.H. Freed: none; A.R. Patel: has received grant support from Astellas; and has received speaking fees from the Medical Education Speakers Network (MESN); R.M. Lang: none.
PY - 2012/6
Y1 - 2012/6
N2 - While pulmonary arterial hypertension is a disease primarily affecting the pulmonary vasculature, the right ventricle plays an integral part in the disease process. Although widely used, two-dimensional echocardiography is limited in visualizing the right ventricle and, therefore, assessment of its structure and function has been largely subjective or invasive. Advanced imaging modalities such as real-time three-dimensional echocardiography and cardiovascular magnetic resonance overcome many challenges of two-dimensional echocardiography and have provided further insight into the pathophysiology of pulmonary arterial hypertension. Indices of right ventricular function obtained from these noninvasive techniques are being assessed for their prognostic capabilities as well as their ability to monitor response to pulmonary arterial hypertension-specific therapies. Future research is needed to compare the accuracy, reproducibility, and prognostic value of each of these parameters to definitively establish the role of cardiovascular imaging in the management of patients with pulmonary arterial hypertension.
AB - While pulmonary arterial hypertension is a disease primarily affecting the pulmonary vasculature, the right ventricle plays an integral part in the disease process. Although widely used, two-dimensional echocardiography is limited in visualizing the right ventricle and, therefore, assessment of its structure and function has been largely subjective or invasive. Advanced imaging modalities such as real-time three-dimensional echocardiography and cardiovascular magnetic resonance overcome many challenges of two-dimensional echocardiography and have provided further insight into the pathophysiology of pulmonary arterial hypertension. Indices of right ventricular function obtained from these noninvasive techniques are being assessed for their prognostic capabilities as well as their ability to monitor response to pulmonary arterial hypertension-specific therapies. Future research is needed to compare the accuracy, reproducibility, and prognostic value of each of these parameters to definitively establish the role of cardiovascular imaging in the management of patients with pulmonary arterial hypertension.
KW - Cardiovascular imaging
KW - Cardiovascular magnetic resonance
KW - Clinical end points
KW - Prognostic parameters
KW - Pulmonaryarterialhypertension
KW - Real-time three-dimensional echocardiography
KW - Right ventricle
KW - Two-dimensional echocardiography
UR - http://www.scopus.com/inward/record.url?scp=84861094594&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861094594&partnerID=8YFLogxK
U2 - 10.1007/s11886-012-0253-2
DO - 10.1007/s11886-012-0253-2
M3 - Review article
C2 - 22327930
AN - SCOPUS:84861094594
VL - 14
SP - 366
EP - 373
JO - Current Cardiology Reports
JF - Current Cardiology Reports
SN - 1523-3782
IS - 3
ER -